Clinical pharmacokinetics of а new original dipeptide anxiolytic GB-115
Pharmacokinetic study of а new original anxiolytic drug GB-115, developed on the basis of endogenous tetrapeptide cholecystokinin, in healthy volunteers was performed. Volunteers were received drug as single 1, 3, 7, 11 or 15 mg tablets. The parent drug in the human blood plasma was detected within...
Saved in:
| Main Authors: | V. P. Zherdev, G. B. Kolyvanov, A. A. Litvin, V. V. Smirnov, L. G. Kolik, S. Yu. Raskin, N. Yu. Ivashkina, T. A. Gudasheva, S. B. Seredenin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2017-02-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of dipeptide anxiolytic GB-115 after oral administration in different animals species and humans
by: S. Yu. Raskin, et al.
Published: (2017-07-01) -
Preclinical study the pharmacokinetics new anxiolytic drug of dipeptide structure GB-115
by: V. P. Zherdev, et al.
Published: (2014-04-01) -
Assessment of pharmacokinetics-pharmacodynamics relationship of tropoxine in rats
by: V. P. Zherdev, et al.
Published: (2016-09-01) -
Experimental assessment of ladasten and GB-115 effects on the antinociceptive tolerance to morphine
by: M. A. Konstantinopolsky, et al.
Published: (2016-03-01) -
Dipeptide cholecystokinin-4 analog attenuates anxiety in "high-emotional" mice BALB/c and in ethanol-withdrawn rats: comparison with phenazepam
by: L. G. Kolik, et al.
Published: (2017-03-01)